Skip to content
ppharmaranks
Menu

Best treatments for systemic mastocytosis

3 products may treat systemic mastocytosis, spanning FDA drug classes such as kinase inhibitor. The current highest-rated option is gleevec. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for systemic mastocytosis, 2 are available as lower-cost generics, spanning classes such as kinase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for systemic mastocytosis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for systemic mastocytosis: 1. Gleevec · 2. Rydapt · 3. Imkeldi

Top-rated treatments for systemic mastocytosis, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$26View →
270/100View →
3Not yet rated$26View →

Full ranking · 3 treatments

Frequently asked

What treats systemic mastocytosis?
Our catalog lists 3 products that may treat systemic mastocytosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is gleevec.
What is the best-rated treatment for systemic mastocytosis?
By our independent recall-safety rating — not an efficacy measure — gleevec ranks highest among the products we list for systemic mastocytosis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat systemic mastocytosis?
Treatments for systemic mastocytosis span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.